A lack of standardized assessment, plus under-treatment, is contributing to the poor prognosis seen in older patients with glioblastoma, researchers have suggested.
The specialists from cancer centers in the UK and USA constructed an anonymized online survey for members of the Society for Neuro-Oncology community to complete. The survey asked about assessment in new patients aged 70 years or over with gliobastoma – the most common primary malignant tumor among adults.